Purple Total Current Assets from 2010 to 2024
| PPBT Stock | USD 0.57 0.02 3.64% |
Total Current Assets | First Reported 2014-12-31 | Previous Quarter 15.8 M | Current Value 11.4 M | Quarterly Volatility 21.1 M |
Check Purple Biotech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Purple Biotech's main balance sheet or income statement drivers, such as Depreciation And Amortization of 208.9 K, Interest Expense of 2.3 M or Selling General Administrative of 4.6 M, as well as many indicators such as Dividend Yield of 0.0, Ptb Ratio of 0.53 or Days Sales Outstanding of 366. Purple financial statements analysis is a perfect complement when working with Purple Biotech Valuation or Volatility modules.
Purple | Total Current Assets |
Latest Purple Biotech's Total Current Assets Growth Pattern
Below is the plot of the Total Current Assets of Purple Biotech over the last few years. It is the total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle. Purple Biotech's Total Current Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Purple Biotech's overall financial position and show how it may be relating to other accounts over time.
| Total Current Assets | 10 Years Trend |
|
Total Current Assets |
| Timeline |
Purple Total Current Assets Regression Statistics
| Arithmetic Mean | 15,416,000 | |
| Geometric Mean | 5,147,572 | |
| Coefficient Of Variation | 118.09 | |
| Mean Deviation | 13,420,800 | |
| Median | 8,514,000 | |
| Standard Deviation | 18,205,316 | |
| Sample Variance | 331.4T | |
| Range | 59M | |
| R-Value | 0.66 | |
| Mean Square Error | 200T | |
| R-Squared | 0.44 | |
| Significance | 0.01 | |
| Slope | 2,699,279 | |
| Total Sum of Squares | 4640.1T |
Purple Total Current Assets History
About Purple Biotech Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Purple Biotech income statement, its balance sheet, and the statement of cash flows. Purple Biotech investors use historical funamental indicators, such as Purple Biotech's Total Current Assets, to determine how well the company is positioned to perform in the future. Although Purple Biotech investors may use each financial statement separately, they are all related. The changes in Purple Biotech's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Purple Biotech's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Purple Biotech Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Purple Biotech. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Total Current Assets | 15.8 M | 20.9 M |
Pair Trading with Purple Biotech
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Purple Biotech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Purple Biotech will appreciate offsetting losses from the drop in the long position's value.Moving against Purple Stock
| 0.46 | MRK | Merck Company Financial Report 6th of August 2024 | PairCorr |
The ability to find closely correlated positions to Purple Biotech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Purple Biotech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Purple Biotech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Purple Biotech to buy it.
The correlation of Purple Biotech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Purple Biotech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Purple Biotech moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Purple Biotech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Purple Stock Analysis
When running Purple Biotech's price analysis, check to measure Purple Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Purple Biotech is operating at the current time. Most of Purple Biotech's value examination focuses on studying past and present price action to predict the probability of Purple Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Purple Biotech's price. Additionally, you may evaluate how the addition of Purple Biotech to your portfolios can decrease your overall portfolio volatility.